Skip to content
10-K

Annual Report

BIOETHICS, LTD.

0001477932-25-005771

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jul 31, 2025 3.6M sh
Shares Diluted FY 2024 · Dec 31, 2024 1.49M sh
Shares Diluted FY 2024 · Dec 31, 2023 1.14M sh
Operating Cash Flow FY 2024 · Dec 31, 2024 −$150.43K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$22.31K
Cash And Equivalents FY 2024 · Dec 31, 2024 $14.66K
Cash And Equivalents FY 2024 · Dec 31, 2023 $138
Stockholders Equity FY 2024 · Dec 31, 2024 −$931.22K
Stockholders Equity FY 2024 · Dec 31, 2023 −$776.27K
Stockholders Equity FY 2024 · Dec 31, 2022 −$679.12K
Current Liabilities FY 2024 · Dec 31, 2024 $945.88K
Current Liabilities FY 2024 · Dec 31, 2023 $776.4K
Total Liabilities FY 2024 · Dec 31, 2024 $945.88K
Total Liabilities FY 2024 · Dec 31, 2023 $776.4K
Current Assets FY 2024 · Dec 31, 2024 $14.66K
Current Assets FY 2024 · Dec 31, 2023 $138
Total Assets FY 2024 · Dec 31, 2024 $14.66K
Total Assets FY 2024 · Dec 31, 2023 $138
Eps Diluted FY 2024 · Dec 31, 2024 −$0.12
Eps Diluted FY 2024 · Dec 31, 2023 −$0.09
Sga Expense FY 2024 · Dec 31, 2024 $122.82K
Sga Expense FY 2024 · Dec 31, 2023 $50.44K
Net Income FY 2024 · Dec 31, 2024 −$176.96K
Net Income FY 2024 · Dec 31, 2023 −$97.15K
Operating Income FY 2024 · Dec 31, 2024 −$122.82K
Operating Income FY 2024 · Dec 31, 2023 −$50.44K
Revenue FY 2024 · Dec 31, 2024 $0
Revenue FY 2024 · Dec 31, 2023 $0